Encarnacion Carol F MD is categorized under Infectious Disease Specialists in Meadville, PA and active since 2007.
Encarnacion Carol F MD was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Infectious Disease Specialists business, which does work in the B2C market, and is classified as a Infectious Disease Specialists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Carol Encarnacion at the company’s single location by writing to 764 Kennedy St # 303, Meadville, Pennsylvania PA 16335 or by phoning (814) 373-2195. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Encarnacion Carol F MD |
| Contact Person: | Carol Encarnacion |
| Address: | 764 Kennedy St # 303, Meadville, Pennsylvania 16335 |
| Phone Number: | (814) 373-2195 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Infectious Disease Specialists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Encarnacion Carol F MD was started in 2007 to provide professional Infectious Disease Specialists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Carol Encarnacion for inquiries that concern Encarnacion Carol F MD by calling the company number (814) 373-2195, as your correspondence is most welcome. Additionally, the physical location of the single location of Encarnacion Carol F MD can be found at the coordinates 41.64117,-80.14489 as well as the street address 764 Kennedy St # 303 in Meadville, Pennsylvania 16335.
For its online presence, you may visit Encarnacion Carol F MD’s website at and engage with its social media outlets through on Twitter and on Facebook.